| Particulars |
|
|
|
| Company Name
| Glenmark Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
28.22 |
B.V. (₹) |
868.30 |
| Sales(₹ Cr.) |
9,226.41 |
NP (₹ Cr.) |
1,744.33 |
| NP Var% |
22.00 |
Div% |
250.00 |
| CPS(₹) |
69.60 |
EPS (₹) |
61.80 |
| Traded Value(₹ Lakhs) |
124.58 |
52 Week High |
2,286.00 |
| 52 Week Low |
1,275.00 |
Price BSE |
1,898.00 |
| Price NSE |
1,898.00 |
Market Capital (₹ Cr.) |
53,561.71 |
| P/C Ratio |
27.30 |
P/E Ratio |
30.70 |
| Price Vs.BV |
2.19 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
2,178.90 |
| NP(₹ Cr.) |
596.30 |
NP Var % |
31.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
8,273.06 |
| OPM |
26.59 |
NP |
1,895.02 |
| NP Var% |
15.83 |
EPS |
66.40 |
| PE |
28.58 |
|
|